Zavegepant
Zavegepant is a pharmaceutical drug with 9 clinical trials. Currently 2 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
1
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
4 of 6 finished
33.3%
2 ended early
2
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Prospective, Open-Label Study Evaluating the Effectiveness of Gepants for Acute Treatment of Migraine in the Emergency Department
A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults
Acute Migraine Treatment in the ED With Gepants
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications
Clinical Trials (9)
A Prospective, Open-Label Study Evaluating the Effectiveness of Gepants for Acute Treatment of Migraine in the Emergency Department
A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults
Acute Migraine Treatment in the ED With Gepants
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications
A Study to Learn About the Study Medicine Called Zavegepant in Healthy Chinese Adult Participants
Safety and Efficacy Active Drug vs. Placebo in Subjects With Asthma
Acute Treatment Trial in Adult Subjects With Migraines
Randomized Trial in Adult Participants With Acute Migraines
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9